Sterling Biotech (Delisted) share price history

BSE: 512299Pharmaceuticals & Biotechnology

Formerly Sterling Tea and Industries

Last traded ₹0.70 on 5 Nov 2018

Delisted on 3 Mar 2023.

Last announcements

The company's own last announcements before its shares stopped trading, routine notices left out.Share news and announcements

  1. Feb 2023

    • 24 Feb · Delisting

      Members of the Exchange are hereby informed that the admission to dealings in securities of the company Sterling Biotech Limited shall be withdrawn (delisted) w.e.f. March 03, 2023 pursuant to Hon ble National Company Law Tribunal (NCLT) order dated November 11, 2022.

  2. Nov 2022

  3. Oct 2022

  4. Jul 2022

    • 20 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022

      No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0

Share price history

Daily closes since Jan 2007, BSE closes Jan 2007 to Jul 2010, adjusted for splits and bonuses

Daily close, ₹ per share

Results

Standalone; ₹ crore, the charts by years to December, then March, the table by quarter. No standalone results on record for the years to Mar 2016 and Mar 2018.Quarterly results

Quarter to Mar 2019, against the quarter before

Revenue
₹89 Crdown 6.31%
Net profit
−₹922 CrQuarter to Dec 2018: ₹37 Cr
Net margin
−1,036.3%

Revenue by year

Net profit by year, a loss in red

  • Net profit
  • Loss
A loss in 7 of the 8 years with results on record

The company moved its year end from December to March: its last year to December on record ended in Dec 2014, its first year to March in Mar 2017.

The years either side of a change of basis do not compare. From the year to Mar 2019, GST replaced excise duty on 1 Jul 2017, and revenue before that day includes the duty.

₹ croreJun 2017Sep 2017Dec 2017Mar 2018Jun 2018Filed 2 FebSep 2018Filed 2 FebDec 2018Filed 12 FebMar 2019
Revenue101–––84829589
Net profit−110–––−2,309−13637−922
Net margin−108.5%–––−2,759.9%−166.1%38.9%−1,036.3%
Standalone. The last eight quarters. The latest is shaded. No results on record for the quarters to Sep 2017, Dec 2017 and Mar 2018.

Business segments

In the quarter to Dec 2018 the company reports one business segment, Manufacture of Chemicals and Chemical Products, which carries all its revenue.

Sterling Biotech share price by year

Each calendar year to 2018.

YearClose at year endChangeHighest closeLowest close
20180.70−82.1%5.100.65
20173.90+9.9%6.353.15
20163.55−51.7%7.453.05
20157.35+5.8%8.204.55
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. The 2018 close is its last trade, on 5 Nov 2018.

Recent sessions

The last 10 trading days to 5 Nov 2018, as traded on BSE.

DateOpenHighLowCloseAverage priceVolume
5 Nov 20180.650.750.650.700.7516,887
29 Oct 20180.650.700.600.700.6536,738
22 Oct 20180.700.750.650.650.701,03,815
15 Oct 20180.600.700.600.700.6155,086
8 Oct 20180.700.750.650.650.701,15,796
1 Oct 20180.700.750.700.700.7124,850
24 Sep 20180.800.800.750.750.7535,056
17 Sep 20180.800.800.800.800.8021,954
10 Sep 20180.850.850.850.850.855,200
3 Sep 20180.900.900.900.900.9017,320
Prices in ₹ per share as traded, not adjusted.

Company details

Legal name
Sterling Biotech Ltd.
BSE code
512299
ISIN
INE324C01038
Industry
Pharmaceuticals & Biotechnology
Listed
Jan 1986
Face value
₹1
Former symbols
STERLINBIO, STERLINTEA
Website
www.sterlingbiotech.in (opens in a new tab)
CIN
L51900MH1985PLC035738
Corporate identity number, the registrar of companies' code for it